ananth annapragada
ananth annapragada
Texas children's hospital
Verified email at
Cited by
Cited by
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
JM Saul, A Annapragada, JV Natarajan, RV Bellamkonda
Journal of Controlled Release 92 (1-2), 49-67, 2003
Computational fluid dynamics simulation of airflow and aerosol deposition in human lungs
N Nowak, PP Kakade, AV Annapragada
Annals of biomedical engineering 31 (4), 374-390, 2003
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
JM Saul, AV Annapragada, RV Bellamkonda
Journal of controlled release 114 (3), 277-287, 2006
A liposomal nanoscale contrast agent for preclinical CT in mice
S Mukundan Jr, KB Ghaghada, CT Badea, CY Kao, LW Hedlund, ...
American Journal of Roentgenology 186 (2), 300-307, 2006
Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors
KM McNeeley, E Karathanasis, AV Annapragada, RV Bellamkonda
Biomaterials 30 (23-24), 3986-3995, 2009
Application of 3-D printing (rapid prototyping) for creating physical models of pediatric orthopedic disorders
ZA Starosolski, JH Kan, SD Rosenfeld, R Krishnamurthy, A Annapragada
Pediatric radiology 44 (2), 216-221, 2014
Long-residence-time nano-scale liposomal iohexol for X-ray–based blood pool imaging
CY Kao, EA Hoffman, KC Beck, RV Bellamkonda, AV Annapragada
Academic radiology 10 (5), 475-483, 2003
Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma
KM McNeeley, A Annapragada, RV Bellamkonda
Nanotechnology 18 (38), 385101, 2007
Folate targeting of drug carriers: a mathematical model
KB Ghaghada, J Saul, JV Natarajan, RV Bellamkonda, AV Annapragada
Journal of controlled release 104 (1), 113-128, 2005
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging
KB Ghaghada, M Ravoori, D Sabapathy, J Bankson, V Kundra, ...
PloS one 4 (10), e7628, 2009
Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography1
E Karathanasis, S Suryanarayanan, SR Balusu, K McNeeley, ...
Radiology 250 (2), 398-406, 2009
Indocyanine green fluorescence in second near-infrared (NIR-II) window
Z Starosolski, R Bhavane, KB Ghaghada, SA Vasudevan, A Kaay, ...
Plos one 12 (11), e0187563, 2017
Synthesis of magnetite nanoparticles and the process of forming Fe-based nanomaterials
S Sun
US Patent 6,962,685, 2005
Long‐circulating liposomal contrast agents for magnetic resonance imaging
AL Ayyagari, X Zhang, KB Ghaghada, A Annapragada, X Hu, ...
Magnetic Resonance in Medicine: An Official Journal of the International …, 2006
Thioaptamer conjugated liposomes for tumor vasculature targeting
AP Mann, RC Bhavane, A Somasunderam, BL Montalvo-Ortiz, ...
Oncotarget 2 (4), 298, 2011
Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers
E Karathanasis, L Chan, L Karumbaiah, K McNeeley, CJ D'Orsi, ...
PLoS One 4 (6), e5843, 2009
Antibiological barrier nanovector technology for cancer applications
J Sakamoto, A Annapragada, P Decuzzi, M Ferrari
Expert opinion on drug delivery 4 (4), 359-369, 2007
T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents—effect of liposome size and internal gadolinium concentration
K Ghaghada, C Hawley, K Kawaji, A Annapragada, S Mukundan Jr
Academic radiology 15 (10), 1259-1263, 2008
Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging
KB Ghaghada, CT Badea, L Karumbaiah, N Fettig, RV Bellamkonda, ...
Academic radiology 18 (1), 20-30, 2011
Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy
E Karathanasis, L Chan, SR Balusu, CJ D'Orsi, AV Annapragada, ...
Biomaterials 29 (36), 4815-4822, 2008
The system can't perform the operation now. Try again later.
Articles 1–20